Early but reversible haemostatic changes in a-symptomatic females expressing COVID-19 antibodiesCOVID-19 항체를 발현하는 무증상 여성의 초기이지만 가역적인 지혈 변화Article Published on 2022-09-012022-09-12 Journal: Thrombosis research [Category] COVID19(2023년), MERS, SARS, 변종, 진단, [키워드] age and gender aggregation antibody Antibody Response Asymptomatic COVID-19 carried change changes in circulating coagulation parameter Cohort cohort study Control coronavirus country COVID-19 COVID-19 antibody COVID-19 pandemic COVID-19-associated coagulopathy Effect effort expressing extracellular vesicle female Female patients globe Haemoglobin highest IgM and IgG individual Infection initial intensive care treatment male Mortality participant Participants pathway Platelet platelet activation Platelet responsiveness. positive positive COVID-19 Prevalence Prothrombin time risk serious complication significant decrease significant increase Spread subject unique vaccination Vaccine viral mutation were assessed with COVID-19 [DOI] 10.1016/j.thromres.2022.07.012 PMC 바로가기 [Article Type] Article
Assessment of Tocilizumab (Humanized Monoclonal Antibody) for Therapeutic Efficacy and Clinical Safety in Patients with Coronavirus Disease (COVID-19)코로나바이러스 감염증(COVID-19) 환자의 치료 효능 및 임상 안전성에 대한 토실리주맙(인간화 단클론항체) 평가Article Published on 2022-08-102022-09-12 Journal: Medicina [Category] SARS, 진단, [키워드] activated acute respiratory distress added adverse effect airways alanine aminotransferase alkaline phosphatase ALP ALT Analysis Anticoagulant ARDS assessment Autoimmune Bacterial baseline C-reactive protein characterized clinical coagulation parameter Coagulopathy control group COVID-19 COVID-19 cases COVID-19 patient COVID-19 patients CRP CRS Cytokine release syndrome Cytokine storm D-dimer discharged Efficacy Endpoint expired fatality ferritin Follow-up humanized monoclonal antibody include infection rate Inflammatory inflammatory conditions inflammatory parameter inflammatory parameters INR institution institutional protocol International lactate dehydrogenase LDH Manifestations material normalized patients of COVID-19 Platelet Pneumonia presenting Prothrombin time provided Pulmonary edema raised receiving respiratory tract infection Result Safety severe COVID-19 patients severe disease significantly higher statistically significant difference survival rate syndrome Teaching the disease the patient therapeutic efficacy Tocilizumab treat Treatment Treatment protocol treatment regimen was performed [DOI] 10.3390/medicina58081076 PMC 바로가기 [Article Type] Article
Coagulation parameters abnormalities and their relation to clinical outcomes in hospitalized and severe COVID-19 patients: prospective study Research Published on 2022-08-012022-10-05 Journal: Scientific Reports [Category] 바이오마커, 임상, 치료법, [키워드] abnormality activated biochemical biochemical parameter clinical Clinical outcome Coagulation coagulation parameter Coagulation parameters Concentration COVID-19 COVID-19 patient COVID-19 severity cut-off D dimer D-dimer death diagnosed difference Dyspnea enrolled fibrinogen hematological Hospitalized inflammatory markers LDH non-severe group Older outcome parameter parameters Partial Patient patients Predictive Prospective Study prothrombin risk Sensitivity and specificity severe COVID-19 severe group Severe patient severity severity of COVID-19 survival the patient time were recorded [DOI] 10.1038/s41598-022-16915-8 [Article Type] Research
Cardiac injury and COVID-19 associated coagulopathy in patients with acute SARS-CoV-2 pneumonia: A rotational thromboelastometry study급성 SARS-CoV-2 폐렴 환자의 심장 손상 및 COVID-19 관련 응고병증: 회전 혈전탄성 측정 연구Article Published on 2022-03-012022-09-11 Journal: Advances in medical sciences [Category] SARS, 치료기술, [키워드] Analysis cardiac injury cardiac troponin Coagulation coagulation parameter coagulative Coagulopathy conducted consecutive patient consecutive patients Coronary Coronary thrombosis coronavirus disease Coronavirus disease 2019 COVID-19 COVID-19 patients cross-sectional study defined Hospitalized hospitalized COVID-19 patient hospitalized COVID-19 patients hypercoagulability Injury males material mechanism median age Mortality no differences no significant differences Other parameter Patient patients Retrospective cross-sectional study Rotational thromboelastometry SARS-CoV-2 significant difference study population systemic inflammatory thromboembolic thromboembolic complications thrombosis Traditional troponin troponin I Whole blood [DOI] 10.1016/j.advms.2021.12.001 PMC 바로가기 [Article Type] Article
Major coagulation disorders and parameters in COVID-19 patientsReview Published on 2022-02-152022-10-31 Journal: European Journal of Medical Research [Category] COVID-19, COVID19(2023년), MERS, SARS, [키워드] addition anticoagulant therapies C-reactive protein cascades cause Coagulation coagulation disorder coagulation parameter Coagulation parameters Coagulopathy Coronavirus disease 2019 coronavirus epidemics COVID-19 COVID-19 infection COVID-19 patient COVID-19 patients Diagnosis disrupt Disseminated intravascular coagulation fibrinogen homeostasis Inflammatory inflammatory markers investigated lactate dehydrogenase Major marker occur parameter patients Platelet Prevalence Previous studies problem Prognosis Prothrombin time reported Research Thromboembolic events thrombotic complication Treatment Venous Thromboembolism viral infection [DOI] 10.1186/s40001-022-00655-6 PMC 바로가기 [Article Type] Review
COVID-19 Induced Coagulopathy (CIC): Thrombotic Manifestations of Viral InfectionOriginal Article Published on 2022-01-102022-10-29 Journal: TH Open: Companion Journal to Thrombosis and Haemostasis [Category] COVID-19, [키워드] Abnormalities abnormality activated acute lung injury acute respiratory distress acute respiratory syndrome affected age alteration ARDS caused Characteristics CIC Clinical finding Coagulation coagulation parameter coagulation test coagulative Coagulopathy consequence coronavirus Coronavirus disease 2019 COVID-19 COVID-19 infection D-dimer Degradation develop disease Disseminated intravascular coagulation dysfunction early phase Evidence exhibiting Fibrinogen levels ICUs Immunity implication incidence increased mortality induced infected patient Inflammation initial intensive care unit involved less manifestation manifested Measures multiple organs overactive Patient patients Platelet Prophylaxis proportion Prothrombin time protocol Respiratory failure respiratory tract resulting SARS-CoV-2 SARS-CoV-2 infected patient severe COVID-19 severe infections Stage standard supportive care syndrome the disease therapeutic thromboembolic thromboembolic complications Thromboembolic event thrombosis venous viral infection with COVID-19 [DOI] 10.1055/s-0042-1744185 PMC 바로가기 [Article Type] Original Article
Cirrhosis-Associated RAS-Inflammation-Coagulation Axis Anomalies: Parallels to Severe COVID-19Article Published on 2021-12-012022-10-30 Journal: Journal of Personalized Medicine [Category] COVID-19, [키워드] abnormal coagulation abnormality ACE acute respiratory distress acute respiratory distress syndrome Angiotensin-converting enzyme Antigen axis C-reactive protein characterized cirrhosis coagulation parameter correlated COVID patient COVID-19 COVID-19 patients CRP D-dimer Endothelial dysfunction exhibited fibrinolysis healthy subject IL-6 Increased increased risk Inflammation interleukin-6 investigated Liver disease Mild nine parameter Patient patients patients with COVID-19 portal hypertension RAS RAS activity renin-angiotensin-system severe COVID-19 severity significantly syndrome systemic inflammation upregulation venous vWF [DOI] 10.3390/jpm11121264 PMC 바로가기 [Article Type] Article
Novel Coronavirus Infection (COVID-19) Related Thrombotic and Bleeding Complications in Critically Ill Patients: Experience from an Academic Medical CenterArticle Published on 2021-11-302022-10-30 Journal: Journal of Clinical Medicine [Category] COVID-19, [키워드] Admission age anticoagulation association baseline characteristics bleeding bleeding event bleeding mortality center clinically coagulation parameter Coagulation parameters Cohort Comorbidity Complication complications convalescent serum COVID-19 COVID-19 patient COVID-19 patients COVID19 Critically ill described died dose event experience ICU Ill incidence INR intensive care unit intermediate dose Intubated IQR major bleeding major bleeding event majority male mechanical ventilation median median age Median BMI Mortality novel Novel coronavirus infection outcome P -value Patient patients Platelet Prophylactic question raised Remdesivir retrospective risk SARS-CoV-2 secondary Sex significantly statistically significant Steroids subject suffered therapeutic anticoagulation thrombosis thrombotic thrombotic event Thrombus Treatment was performed [DOI] 10.3390/jcm10235652 PMC 바로가기 [Article Type] Article
Hematologic and coagulopathy parameter as a survival predictor among moderate to severe COVID-19 patients in non- ICU ward: a single-center study at the main referral hospital in Surabaya, East Java, IndonesiaResearch Article Published on 2021-11-292022-10-31 Journal: F1000Research [Category] COVID-19, MERS, SARS, [키워드] age Analysis and well-being average Chronic kidney disease Coagulation coagulation parameter Coagulation parameters Coagulopathy comorbid Coronary Coronary heart disease COVID-19 COVID-19 case COVID-19 patient COVID-19 patients CRP D-dimer death Deceased decrease Diabetes Mellitus disease East good health hematologic hematology hospital ICU Increases independent Indonesia Isolation room lymphocyte lymphocyte counts majority moderate Mortality neutrophil NLR parameter parameters Patient positive predict Research Result retrospective risk factor severe COVID-19 patient significantly single-center study survival tested the disease treated WBC White blood cell [DOI] 10.12688/f1000research.53803.3 PMC 바로가기 [Article Type] Research Article
Role of Coagulation Profile in Predicting Disease Severity Among Patients of COVID-19Pathology Published on 2021-10-292022-10-31 Journal: Cureus [Category] COVID-19, [키워드] activated activated partial thromboplastin time acute respiratory syndrome Admission Affect analyzed association blood coagulation tests calculated caused Chi-square coagulation cascade coagulation parameter coronavirus disease 19 Coronavirus-2 COVID-19 COVID-19 patient COVID-19 patients cut-off value D-dimer disease severity evaluated fibrin degradation products fibrinogen independent t-test non-severe group P-value parameter Patient positive predict Predictive profile Prothrombin time Receiver operator characteristic Result Retrospective study ROC role rRT-PCR SARS-CoV-2 severe group severity significantly higher the disease [DOI] 10.7759/cureus.19124 PMC 바로가기 [Article Type] Pathology